Teva proposes 156-acre campus in Warrington

Teva Pharmaceuticals USA, the maker of generic drugs with headquarters in North Wales, has proposed a warehouse and office campus on 156 acres in the Eureka Village section of Warrington, Bucks County, Warrington and Teva officials say.

The development comes as a Route 202 widening project reaches central Bucks County, allowing easier access to the Pennsylvania Turnpike.

The first phase of the Teva project would focus on warehouse buildings, Warrington officials say.

Rebecca A. Keifer, chairwoman of the Warrington Board of Supervisors, said she was concerned about truck traffic in the once-rural Bucks County town and the fact that a corporate campus with a big warehouse does not fit with the small-town ambience planned for the area.

Warrington officials have scheduled a special meeting for 7:30 p.m. Feb. 2 at Mill Creek Elementary School to discuss the proposed Teva development.

In a statement, Teva said it was considering sites for its campus in Pennsylvania and New Jersey. "We have no timetable, but anticipate that the process would take several years to complete," the company said.

Teva, whose parent company is based in Israel, declined to say how much it would invest in the more than one-million-square-feet of warehousing and office buildings.

And the company did not say whether it would move its headquarters to the new site.

Keifer said the anticipated six trucks an hour at the warehouse facility - which would operate around-the-clock - could strain local roads.

The Teva proposal "came as a shock to me," Keifer said, adding that "I am not saying I am opposed to something I have not seen."